Aarey Drugs & Pharmaceuticals Limited incorporated in 1990, is engaged in the business of
--> Manufacturing of active pharmaceutical ingredients (APls), intermediates and specialty chemicals.
--> Trading of Industrial Solvents & Chemicals
Our high-quality pharmaceutical products cater to well-established pharmaceuticals formulation manufacturers and pharmaceutical merchant exports & our vide array of industrial chemicals & solvents help us keeping our costs in check as well as act as a supplier to different industries across the globe.
A well reputed firm which is listed on the BOMBAY STOCK EXCHANGE (BSE), but still held together and functions as a closely held family business where the best interests of all associated with us are always considered to be at the fore.
Mr. Mihir Ghatalia completed his B.S. in chemical Engineering from Virginia Polytechnic Institute & State University in the United Stets. Initially he has worked as a consultant for 2 years with French based, The Renoir Group; which specializes in management & industrial projects. After that started leading the management of our Company and now supervises its routine operations. He is a new generation entrepreneur, and his strong academics, skill sets and expertise have helped us to roll out manufacturing at the Tarapur plant. He has worked in various teams including designing, costing, building, maintenance, safety and quality control of effluent treatment plants. His ground-level expertise, sharp business acumen and visionary leadership have helped us evolve our business and achieve consistent results.
We are one of the rising manufacturer representatives and suppliers of pharmaceutical raw materials, Chemicals, Pharmaceuticals ingredients, API’s Drugs, Food Colours and Flavours. Our pharmaceutical products are sourced from the authentic vendors to assure the quality and effectiveness. Widely used by the reputed Pharmaceutical formulation Manufacturers and Pharmaceutical Merchant exporters, our pharmaceutical products are in high demands.
To grow towards becoming a transnational Pharma Company through continuous research & innovative technology
To become a leading global manufacturer of speciality chemicals & API intermediates by 2020.